Search Recorded Webinars:
GlobalCompliancePanel
GlobalCompliancePanel
Featured Speakers
Robert Kunka Robert Kunka
President & Clinical Drug Development Consultant,
The Kunka Group, Inc.

Albert A. Ghignone Albert A. Ghignone
Chief Executive Officer and President,
AAG Incorporated

Dev Raheja Dev Raheja
Author - Safer Hospital Care (Taylor & Francis),
Patient System Safety
Partial Client List
Customer Testimonials
Nice response to my questions and good suggestions for moving forward.

Some of these sessions are too basic - this one had a good mix of basic and details. The tips are helpful. One comment: a little more discussion regarding the use of Detection in FMEAs would be useful since many do not advocate its use. Thanks,

I especially liked that the Q&A session after the webinar was long enough to not only address my own questions but also to learn from the questions from the other participants in the webinar.

Very thorough understanding of the history/progression of the guidances, and very helpful evaluation of current and potential directions. Excellent presentation skills, very engaging.

Like
8 People like this

Call: 800-447-9407

Fax: 302-288-6884

May 28th & 29th, 2015
SFO, CA

Brian L Tuttle
Why You Should be Worried About HIPAA

It is absolutely imperative that you are proactive and not reactive with your compliance program, this is a necessary evil and you need to protect your practice or your business and limit risks from the imminent Federal audits.

Registration

June 4th & 5th, 2015
San Diego, CA

Casper Uldriks
FDA Inspections: Before, During and After

FDA's inspection program follows well-established procedures and conducts the inspections with as much consistency as possible. FDA trains its investigators from day one.

Registration

June 11th & 12th, 2015
Sydney, Australia

Steven Walfish
Using Statistical Methods for ICH Guidelines

This hands-on course will provide attendees with an understanding of how to apply statistical methods to the ICH Q series guidelines. The course will deliver tools, templates and insight that will allow participants to immediately begin implementation within their organization/firm.

Registration

June 18th & 19th, 2015
Seattle, WA

Heath Rushing
Risk Analysis and Design of Experiments in Process Validation and Development

Prior to developing a process control plan as part of an overall risk management strategy, process development studies must be completed.

Registration

More
Customer Testimonials
Nice response to my questions and good suggestions for moving forward.

Todd Rist

Simplexity



Some of these sessions are too basic - this one had a good mix of basic and details. The tips are helpful. One comment: a little more discussion regarding the use of Detection in FMEAs would be useful since many do not advocate its use. Thanks,

Lance Mason

Smiths Medical



I especially liked that the Q&A session after the webinar was long enough to not only address my own questions but also to learn from the questions from the other participants in the webinar.

Dania P

Next Breath



Very thorough understanding of the history/progression of the guidances, and very helpful evaluation of current and potential directions. Excellent presentation skills, very engaging.

Karen Wesley

Dendreon



Copyright © 2015 GlobalCompliancePanel. All rights reserved. Netzealous